MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial‐mesenchymal transition of glioblastoma cells in vitro and in vivo

Chemotherapy with temozolomide (TMZ) is the traditional treatment for glioblastoma (GBM). Nevertheless, majority of GBM patients have recurrence from resistance to the chemotherapy. Herein, we examined combinational effects of MCCK1 (a specific and effective IKKε inhibitor) with TMZ in GBM U251MG an...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tie, Li, Anqi, Xu, Yulun, Xin, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382719/
https://www.ncbi.nlm.nih.gov/pubmed/30656846
http://dx.doi.org/10.1002/cam4.1951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382719/
https://www.ncbi.nlm.nih.gov/pubmed/30656846
http://dx.doi.org/10.1002/cam4.1951

Ejemplares similares